Cargando…

Clinical Relevancy of Circulating Tumor Cells in Breast Cancer: Epithelial or Mesenchymal Characteristics, Single Cells or Clusters?

Metastatic breast cancer (MBC) is typically an incurable disease with high mortality rates; thus, early identification of metastatic features and disease recurrence through precise biomarkers is crucial. Circulating tumor cells (CTCs) consisting of heterogeneous subpopulations with different morphol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fridrichova, Ivana, Kalinkova, Lenka, Ciernikova, Sona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603393/ https://www.ncbi.nlm.nih.gov/pubmed/36292996 http://dx.doi.org/10.3390/ijms232012141

Ejemplares similares

Targeting DNA Methylation in Leukemia, Myelodysplastic Syndrome, and Lymphoma: A Potential Diagnostic, Prognostic, and Therapeutic Tool
por: Kalinkova, Lenka, et al.
Publicado: (2022)

Clinical Significance of microRNAs in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation
por: Sevcikova, Aneta, et al.
Publicado: (2023)

miR-205-5p Downregulation and ZEB1 Upregulation Characterize the Disseminated Tumor Cells in Patients with Invasive Ductal Breast Cancer
por: Kalinkova, Lenka, et al.
Publicado: (2021)

Discriminating miRNA Profiles between Endometrioid Well- and Poorly-Differentiated Tumours and Endometrioid and Serous Subtypes of Endometrial Cancers
por: Kalinkova, Lenka, et al.
Publicado: (2020)

miR-497-5p Decreased Expression Associated with High-Risk Endometrial Cancer
por: Fridrichova, Ivana, et al.
Publicado: (2020)

Decreased methylation in the SNAI2 and ADAM23 genes associated with de-differentiation and haematogenous dissemination in breast cancers
por: Kalinkova, Lenka, et al.
Publicado: (2018)

Epithelial-mesenchymal transition status of circulating tumor cells in breast cancer and its clinical relevance
por: Zhou, Jiaojiao, et al.
Publicado: (2020)

A single-cell atlas of the healthy breast tissues reveals clinically relevant clusters of breast epithelial cells
por: Bhat-Nakshatri, Poornima, et al.
Publicado: (2021)

Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer
por: Zhao, Ren, et al.
Publicado: (2016)

Epithelial-to-Mesenchymal Transition Gene Signature in Circulating Melanoma Cells: Biological and Clinical Relevance
por: Rapanotti, Maria Cristina, et al.
Publicado: (2023)

The Significance of Epithelial-to-Mesenchymal Transition for Circulating Tumor Cells
por: Kölbl, Alexandra C., et al.
Publicado: (2016)

Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancer
por: Mego, M., et al.
Publicado: (2015)

Heterogeneous Manifestations of Epithelial–Mesenchymal Plasticity of Circulating Tumor Cells in Breast Cancer Patients
por: Tashireva, Liubov A., et al.
Publicado: (2021)

Expression of Stem Cell and Epithelial-Mesenchymal Transition Markers in Circulating Tumor Cells of Breast Cancer Patients
por: Krawczyk, Natalia, et al.
Publicado: (2014)

A disintegrin and metalloprotease 23 hypermethylation predicts decreased disease‐free survival in low‐risk breast cancer patients
por: Zmetakova, Iveta, et al.
Publicado: (2019)

Classification of Circulating Tumor Cells by Epithelial-Mesenchymal Transition Markers
por: Wu, Shiyang, et al.
Publicado: (2015)

Clinical Implications of Circulating Tumor Cells of Breast Cancer Patients: Role of Epithelial–Mesenchymal Plasticity
por: McInnes, Linda M., et al.
Publicado: (2015)

Epithelial Cell Adhesion Molecule: An Anchor to Isolate Clinically Relevant Circulating Tumor Cells
por: Eslami-S, Zahra, et al.
Publicado: (2020)

Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells
por: Kasimir-Bauer, Sabine, et al.
Publicado: (2012)

Down-regulation of traditional oncomiRs in plasma of breast cancer patients
por: Jurkovicova, Dana, et al.
Publicado: (2017)

MicroRNAs Contribute to Breast Cancer Invasiveness
por: Fridrichova, Ivana, et al.
Publicado: (2019)

Detection of circulating tumor cells and evaluation of epithelial-mesenchymal transition patterns of circulating tumor cells in ovarian cancer
por: Jie, Xiao-Xiang, et al.
Publicado: (2022)

Tumor microbiome – an integral part of the tumor microenvironment
por: Ciernikova, Sona, et al.
Publicado: (2022)

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients
por: Aktas, Bahriye, et al.
Publicado: (2009)

Role of Epithelial-to-Mesenchymal Transition for the Generation of Circulating Tumors Cells and Cancer Cell Dissemination
por: Noubissi Nzeteu, Gaetan Aime, et al.
Publicado: (2022)

Prognostic value of epithelial–mesenchymal transition circulating tumor cells in female breast cancer: A meta-analysis
por: Zhao, Qiang, et al.
Publicado: (2022)

Clinical Relevance of Immune Checkpoints on Circulating Tumor Cells in Breast Cancer
por: Papadaki, Maria A., et al.
Publicado: (2020)

Single Cell Analysis of Inertial Migration by Circulating Tumor Cells and Clusters
por: Zhou, Jian, et al.
Publicado: (2023)

Epithelial Mesenchymal Transition: A New Insight into the Detection of Circulating Tumor Cells
por: Barrière, Guislaine, et al.
Publicado: (2012)

Cancer metastasis through the prism of epithelial‐to‐mesenchymal transition in circulating tumor cells
por: Micalizzi, Douglas S., et al.
Publicado: (2017)

Epithelial-mesenchymal transition of circulating tumor cells in prostate cancer is promoted by survivin
por: Yang, Faying, et al.
Publicado: (2020)

Microcalcifications in breast cancer: an active phenomenon mediated by epithelial cells with mesenchymal characteristics
por: Scimeca, Manuel, et al.
Publicado: (2014)

Epithelial-Mesenchymal-Transition-Like Circulating Tumor Cell-Associated White Blood Cell Clusters as a Prognostic Biomarker in HR-Positive/HER2-Negative Metastatic Breast Cancer
por: Guan, Xiuwen, et al.
Publicado: (2021)

Involvement of immune system and Epithelial–Mesenchymal-Transition in increased invasiveness of clustered circulatory tumor cells in breast cancer
por: Khoshbakht, Samane, et al.
Publicado: (2021)

Mesenchymal Characteristics and Predictive Biomarkers on Circulating Tumor Cells for Therapeutic Strategy
por: Okabe, Takahiro, et al.
Publicado: (2020)

In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis
por: Bulfoni, Michela, et al.
Publicado: (2016)

Clinical Significance of Circulating Tumor Cell Induced Epithelial-Mesenchymal Transition in Patients with Metastatic Colorectal Cancer by Single-Cell RNA-Sequencing
por: Kozuka, Masahiro, et al.
Publicado: (2021)

Expression of SOCS1 and CXCL12 Proteins in Primary Breast Cancer Are Associated with Presence of Circulating Tumor Cells in Peripheral Blood()
por: Smolkova, Bozena, et al.
Publicado: (2016)

Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients
por: Kallergi, Galatea, et al.
Publicado: (2011)

Spectrum of Epithelial-Mesenchymal Transition Phenotypes in Circulating Tumour Cells from Early Breast Cancer Patients
por: Markiewicz, Aleksandra, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d85e6ab6lndbscjvla8u1m6k55